Incidence of Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates That Test Susceptible to Cephalosporins and Aztreonam by the Revised CLSI Breakpoints

被引:10
|
作者
McWilliams, Carla S. [1 ]
Condon, Susan [2 ]
Schwartz, Rebecca M. [3 ,4 ]
Ginocchio, Christine C. [2 ,4 ]
机构
[1] North Shore LIJ Hlth Syst, Dept Med, Div Infect Dis, Manhasset, NY USA
[2] North Shore LIJ Hlth Syst Labs, Dept Pathol & Lab Med, Lake Success, NY USA
[3] North Shore LIJ Hlth Syst, Dept Populat Hlth, Great Neck, NY USA
[4] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA
关键词
PIPERACILLIN-TAZOBACTAM; CEFEPIME THERAPY; ENTEROBACTERIACEAE; INFECTIONS; IMPACT;
D O I
10.1128/JCM.03613-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The incidence of aztreonam and cephalosporin susceptibility, determined using the revised CLSI breakpoints, for extendedspectrum-beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolates was evaluated. Our analysis showed that results for aztreonam and/or> 1 cephalosporin were reported as susceptible or intermediate for 89.2% of ESBLproducing E coli isolates (569/638 isolates) and 67.7% of ESBL-producing K. pneumoniae isolates (155/229 isolates).
引用
收藏
页码:2653 / 2655
页数:3
相关论文
共 50 条
  • [11] Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from hospitals in Lithuania
    Seputiene, Vaida
    Linkevicius, Marius
    Bogdaite, Aurelija
    Povilonis, Just
    Planciuniene, Rita
    Giedraitiene, Agne
    Pavilonis, Alvydas
    Suziedeliene, Edita
    JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 59 (10) : 1263 - 1265
  • [12] Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread
    Suzuki, Satowa
    Shibata, Naohiro
    Yamane, Kunikazu
    Wachino, Jun-ichi
    Ito, Kenitiro
    Arakawa, Yoshichika
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (01) : 72 - 79
  • [13] Extended-spectrum cephalosporins and the inoculum effect in tests with CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli: Potential clinical implications of the revised CLSI interpretive criteria
    Kang, Cheol-In
    Cha, Min Kyeong
    Kim, So Hyun
    Wi, Yu Mi
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Lee, Nam Yong
    Song, Jae-Hoon
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (05) : 456 - 459
  • [14] Extended-Spectrum-β-Lactamase Producing Multidrug Resistant Klebsiella pneumoniae Isolates from Pediatrics
    Hayat, Sumreen
    Siddique, Muhammad Hussnain
    Aslam, Bilal
    Nadeem, Habibullah
    Ashraf, Asma
    Saqalein, Muhammad
    Khurshid, Mohsin
    Shahzad, Naveed
    Muzammil, Saima
    PAKISTAN JOURNAL OF ZOOLOGY, 2019, 51 (04) : 1251 - 1257
  • [15] Extended-Spectrum-β-Lactamase-Producing Escherichia coli as Intestinal Colonizers in the German Community
    Valenza, Giuseppe
    Nickel, Silke
    Pfeifer, Yvonne
    Eller, Christoph
    Krupa, Elzbieta
    Lehner-Reindl, Verena
    Hoeller, Christiane
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1228 - 1230
  • [16] Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli
    Chopra, Teena
    Marchaim, Dror
    Veltman, Jennifer
    Johnson, Paul
    Zhao, Jing J.
    Tansek, Ryan
    Hatahet, Dania
    Chaudhry, Khawar
    Pogue, Jason M.
    Rahbar, Hiro
    Chen, Ting-Yi
    Thientu Truong
    Rodriguez, Victor
    Ellsworth, Joseph
    Bernabela, Luigino
    Bhargava, Ashish
    Yousuf, Adnan
    Alangaden, George
    Kaye, Keith S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 3936 - 3942
  • [17] Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
    Lee, Nan-Yao
    Huang, Wei-Han
    Tsui, Ko-Chung
    Hsueh, Po-Ren
    Ko, Wen-Chien
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 70 (01) : 150 - 153
  • [18] Fosfomycin susceptibility among extended-spectrum-β-lactamase-producing Escherichia coli in Nottingham, UK
    Chislett, R. J.
    White, G.
    Hills, T.
    Turner, D. P. J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (05) : 1076 - 1077
  • [19] Multidirectional dynamic model for the spread of extended-spectrum-β-lactamase-producing Escherichia coli in the Netherlands
    Costa, Eduardo de Freitas
    Hagenaars, Thomas J.
    Dame-Korevaar, Anita
    Brouwer, Michael S. M.
    de Vos, Clazien J.
    MICROBIAL RISK ANALYSIS, 2022, 22
  • [20] Risk factors for bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
    Ferrandez Quirante, Olivia
    Grau Cerrato, Santiago
    Luque Pardos, Sonia
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 15 (04) : 370 - 376